thrombin-induced increase in Factor VIII coagulant activity. These data demonstrate that the form of VIII:CAg detected in normal plasma is not covalently linked to VIII:vWF multimers and is absent in plasma from five hemophilia A patients. Thrombininduced proteolysis of VIII:CAg can be detected in microliter quantities of normal plasma.
Individuals with the X chromosome-linked clotting disorder hemophilia A lack, or have an inactive form of, the protein responsible for Factor VIII coagulant activity (VIII:C). VIIILC is also decreased or absent in patients with an autosomal disorder, von Willebrand disease. In addition, these individuals lack sufficient quantities offunctional von Willebrand factor (VIII:vWF), a protein necessary for optimal adhesion of platelets to subendothelial surfaces (1, 2) .
The low plasma concentration ofVIII:C and VIII:vWF (3, 4) , their tendency to copurify, and the susceptibility, particularly of VIII:C, to proteolysis (5-7) have hampered the characterization of these proteins. Whether VIII:C and VIII:vWF are two distinct proteins (8) (9) (10) or are covalently linked and become separated only after proteolysis (11, 12) is uncertain. VIII:vWF is a multimeric protein, ranging from -1 x 106 to '20 x 106 in Mr) and is composed of disulfide-linked monomers of Mr 2.3 x 105 (13, 14) . When separated from VIII:vWF by high salt concentrations (15, 16) or mild reducing conditions (4) , VIII:C has been estimated to have Mr of 2.2 x 104 (17) to -3 x 105 (4, 7) . Trace amounts of thrombin or other plasma proteins result in changes of VIII:C activity and Mr (4, 5, 7) .
Recently, fluid-phase immunoradiometric assays have been developed (18) (19) (20) to quantify Factor VIII coagulant antigen (VIII:CAg) in plasma. Human allogeneic antibodies used in these assays were obtained from hemophilia A patients with circulating anti-VIII:C antibodies which developed after transfusions with blood products containing normal VIII:C activity. These antibodies neutralize VIII:C activity but do not usually react with VIII:vWF or other plasma proteins.
We used NaDodSO4 gel electrophoresis to examine the interaction of l"I-labeled anti-(VIII:CAg) Fab with VIII:CAg. (21) . Platelet-poor plasma was separated by two centrifugations at 5000 x g for 3 min (22°C). Some samples also contained diisopropyl fluorophosphate (iPr2P-F; Aldrich) at final concentrations of2 mM with heparin, Trasylol (Mobay), and hirudin (Sigma) at 2, 100, and 2 units/ml, respectively. Plasma samples were either used immediately or stored at -70°C up to 3 months. A normal plasma pool was composed ofplasma from 14 individuals.
VIII:C assays and quantitative electroimmunoassays for VIII:vWf were performed as described (22) .
Preparation of Human Anti-VIII:CAg-125I-Labeled Fab.
IgG from a patient with an VIII:C inhibitor was isolated by (NH4)2SO4 precipitation and DEAE-cellulose chromatography (23) and then was incubated for 2 hr with papain (24 assay-i.e., at higher concentrations of plasma, an increased amount of radioactivity could be precipitated. The VIII:CAg and VIII:C levels were determined for each plasma sample by using standard curves derived from dilutions of normal plasma. In the case of VIII:CAg, the standard curve was derived from a least-squares linear regression analysis of the logarithm of bound radioactivity (cpm) versus logarithm of plasma dilutions. VIII:CAg and VIII:C values determined independently were then plotted against each other to determine the correspondence between these values. Plasma from hemophiliacs was used undiluted in this assay.
Preparation of Samples for NaDodSO4 Gel Electrophoresis.
In a typical experiment, 22 Al of pooled normal plasma containing 200 units of Trasylol per ml were mixed with 22 ,ul of stock 125I-Fab, 1.9 pl of 45% polyethylene glycol 4000, and 2.5
pl of iPr2P-F/hirudin, and then incubated for 2 hr at 370C. Samples were also prepared from thrombin-activated plasma. Purified thrombin (20 units/ml in VBS) was added at 220C to pooled normal plasma, containing 200 units of Trayslol per ml, to give a final thrombin concentration of0.25 unit/ml ofplasma. Aliquots (22 ,1) were withdrawn at intervals and added to 26.4 ,ul of the 125I-Fab/iPr2P-F/hirudin/polyethylene glycol solution. A final concentration of 2.5 units of thrombin per ml was also used to achieve more extensive proteolysis. The latter samples were incubated at 37°C for 10 min before addition to the 251-Fab/iPr2P-F/hirudin/polyethylene glycol solution and then incubated for an additional 2 hr at 37°C. Aliquots (10,ul) were also withdrawn from thrombin-activated plasma at 3-min intervals, diluted in 0.8 ml of VBS, and analyzed immediately by the one-stage VIII:C assay.
The capacity of hirudin plus iPr2P-F to block thrombin activity was measured by a colorimetric assay (27) . Thrombin activity was undetectable within 30 sec after the addition of iPr2P-F/hirudin. NaDodSO4 Gel Electrophoresis and Autoradiography. After 2-hr incubation at 37°C, the plasma plus 125I-Fab samples were mixed with an equal volume of 2% NaDodSOJ8 M urea/2 mM EDTA/0.05 M Tris HCl, pH 8.0. The solution was incubated at 370C for 20 min, and 30-,ul aliquots were applied to 3-mmthick 3% polyacrylamide/0.5% agarose slab gels, 13 x 10.5 cm (28) cast on Gel-Bond (Marine Colloids) prepared the previous day. Electrophoresis was performed at 75 V for 0.5 hr and 120 V for 1.5 hr.
The gels were fixed and stained overnight in 0.0035% Coomassie blue R-250/10% isopropanol/10% acetic acid, destained for 7 hr in 7.5% acetic acid/5% methanol, soaked for 1 hr in 2% glycerol/10% acetic acid, and kept in a drying oven at 500C for 18 hr.
For autoradiography, the dried gels were kept for 24 hr at -700C with Kodak XR-5 x-ray film in a cassette containing two Cronex Lightning-Plus intensifying screens.
The apparent Mr of antigen-antibody complexes was determined by interpolation on a straight line derived by plotting migration distance versus logarithm of Mr of the Coomassiestained proteins fibronectin, a2-macroglobulin, fibrinogen, IgG, albumin, thyroglobulin, ferritin, and 14C-labeled phosphorylase b (New England Nuclear).
Column Chromatography and Sucrose Density Centrifugation. A 0.5-ml aliquot ofnormal citrated platelet-poor plasma with proteolytic inhibitors (see above) was incubated within 15 min ofvenipuncture with an equal volume ofstock 125I-Fab and polyethylene glycoViPr2P-F/hirudin in the same proportion used for NaDodSO4 gel electrophoresis. After incubation at 370C for 2 hr, the sample was chromatographed at 370C on Sephacryl S-300 (1.6 X 88 cm) in VBS at pH 7.5 and containing 38 mM E-aminocaproic acid, 2 mM iPr2P-F, Trasylol at 2000 units/liters, hirudin at 200 units/liter, bovine serum albumin at 0.1 g per liter, and 0.02% Na azide. Plasma samples collected in citrate alone and stored frozen at -700C had the same elution pattern as citrated plasma containing proteolytic inhibitors. The partition coefficient, K&a (29) was used (30) to determine the Stoke's radius. Fibrinogen, apoferritin, aldolase, catalase, IgG, and albumin were standards.
The sedimentation coefficient ofthe 125j-Fab-VIII:CAg complex was determined in a 15-45% linear sucrose density gradient in 0.14 M NaCV0.02 M imidazole, pH 7. 
Reaction of 125I-Fab with Normal and Hemophilic Plasma
Examined by NaDodSOJPolyacrylamide Gel Electrophoresis. To determine the Mr of VIII:CAg-'25I-Fab complexes in normal and hemophilic individuals, we used NaDodSOJpolyacrylamide agarose gel electrophoresis (Fig. 2) . Normal plasma samples were prepared under various conditions to test the possibility that Mr heterogeneity of VIII:CAg might be caused by in vitro proteolysis during collection or storage. Blood was drawn directly into solutions containing ACD, heparin, Trasylol, and hirudin or ACD alone. In addition, iPr2P-F was added to the plasma containing the proteolytic inhibitor mixture within 15 min of venipuncture (after centrifugation of blood samples). Plasma from one donor and pooled normal plasma in ACD were stored at -70°C for 2 months before examination. All ofthese plasma samples were incubated for 2 hr at 37°C with a solution of 1"I-Fab/iPr2P-F/hirudin and then subjected to NaDodSO4 gel electrophoresis.
The patterns ofCoomassie blue-stained proteins from normal and hemophilic plasma samples were indistinguishable except for variation in intensity of individual bands ( Fig. 2A) .
On autoradiographs of 3% polyacrylamide/0.5% agarose gels, the '25I-Fab-VIII:CAg complex that formed in normal plasma was a major band with apparent Mr 3.2 x 105 (Fig. 2B ). In addition, minor bands were present in all normal plasma samples. The most prominent of these had Mr 1.85 X 105. Less distinct bands corresponded to Mr values of 2.5 X 105 and 1.7 x 105. These minor bands were present in all normal plasma samples regardless of storage time or presence of inhibitors.
These observations suggest that 125I-Fab detects several types ofVIII:CAg which occur in vivo, perhaps related to proteolysis. However, the presence ofsome in vitro proteolysis ofthe major VIII:CAg, despite the presence ofproteolytic inhibitors, cannot be excluded absolutely. No additional bands were associated with VIII:vWF when plasma samples were examined on 1.5% polyacrylamide/0.5% agarose gels which resolve VIII:vWF multimers into many oligomeric components (22) . In contrast, all five hemophilic plasma samples examined in this study had no radioactive band at Mr 3. Treated with '25I-Fab. To confirm the Mr determination of the major antibody-antigen complex estimated by the modified NaDodSO4 gel procedure, column chromatography and sucrose density gradient centrifugation were performed. In the elution profile of hemophilic plasma (Fig. 3A ) most of the radioactivity was free "2I-Fab with much smaller amounts of radioactivity in a region extending from the void volume to the 125I-Fab peak.
In contrast, major quantities of radioactivity were in the void volume (peak 1) and near the position of fibrinogen (peak 2) in Samples were analyzed by incubation with '25I-Fab followed by NaDodSOd3% polyacrylamide/0;5% agarose gel electrophoresis. Gels were stained with Coomassie blue (A) and autoradiograms were prepared (B). Lanes: 1, hemophilic plasma; 2-8, samples withdrawn from normal plasma into iPr2P-F/hirudin at the indicated times after addition of thrombin/ml (final concentration, 0.25 unit/ml); 9, one normal plasma sample incubated for 10 min at 37C.with thrombin at 2.5 unit/ml (final concentration). Fibrin was removed before addition of thrombin-treated samples to the gels. the elution profile obtained from normal plasma (Fig. 3B) by NaDodSO4 gel electrophoresis (Fig. 4 ).
An increase in the 125I-FabLVIII:CAg complex, Mr 1.7 X 105, was detected in plasma within 1 Time after thrombin addition, min FIG. 5. Thrombin activation of VIII:C in plasma. At the times indicated after addition of purified thrombin (0.25 unit/ml, final concentration) to pooled normal plasma, 10-1.l aliquots were withdrawn and diluted 1:80, and the VUI:C activity of the sample was determined by one-stage VIII:C assay using hemophilic plasma devoid of VIII:C activity. (6, 33) . One series of studies (11, 12) The NaDodSO4polyacrylamide gel procedure described here should prove useful for detecting VIII:CAg forms present during the purification of Factor VIII as well as in the plasma of patients with abnormalities of VIII:C.
